Children's Hospital of Philadelphia appointed Sarah Tasian, MD, as section chief of hematologic malignancies, the hospital said this month.
Dr. Tasian is a pediatric oncologist and physician-scientist at the hospital who specializes in caring for children with cancers that affect the blood, bone marrow and lymph nodes.
"She is uniquely suited for this new role, and as a current CHOP faculty member, has established herself as a world leader in basic, translational and clinical research in leukemia, with a focus on developing new precision medicine therapies and immunotherapies for high risk and relapsed acute leukemias," Stephen Hunger, MD, chief of oncology at the hospital, said in a news release.
Dr. Tasian stepped into her role July 1 and succeeded Richard Aplenc, MD, PhD, who held the role for 13 years.